Molecular consequences of altered neuronal cholesterol biosynthesis

Journal of Neuroscience Research

Volumn 87, Issue 4, 2009, Pages 866-875

  Korade, Željka ^a,b   Kenworthy, Anne K ^c   Mirnics, Károly ^b,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Department of Molecular Physiology and Biophysics ^*  (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Cholesterol; Gene expression; Lipid metabolism; Neuroblastoma; SREBP

Indexed keywords

7 DEHYDROCHOLESTEROL REDUCTASE; CHAPERONE; CHOLESTEROL; EARLY GROWTH RESPONSE FACTOR 1; FATTY ACID SYNTHASE; OXIDOREDUCTASE; PROTEINASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SQUALENE SYNTHASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTOME; UNCLASSIFIED DRUG; 7-DEHYDROCHOLESTEROL REDUCTASE; FATTY ACID; SERINE PROTEINASE; SIGNAL PEPTIDE; SITE 1 PROTEASE; SITE-1 PROTEASE; STEROL; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, NORTHERN; CELL LINE; CHOLESTEROL; DOWN-REGULATION; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; GENE EXPRESSION; GENE EXPRESSION PROFILING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEURONS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMERASE CHAIN REACTION; PROPROTEIN CONVERTASES; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROLS; TRANSFECTION; VESICULAR TRANSPORT PROTEINS;

EID: 63849292182     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21917     Document Type: Article

References (65)

1. Allende D, Vidal A, McIntosh TJ. 2004. Jumping to rafts: gatekeeper role of bilayer elasticity. Trends Biochem Sci 29:325-330.
2. Anitei M, Pfeiffer SE. 2006. Myelin biogenesis: sorting out protein trafficking. Curr Biol 16:R418-R421.
3. Bacia K, Schwille P, Kurzchalia T. 2005. Sterol structure determines the separation of phases and the curvature of the liquid-ordered phase in model membranes. Proc Natl Acad Sci U S A 102:3272-3277.
4. Bae SH, Lee JN, Fitzky BU, Seong J, Paik YK. 1999. Cholesterol biosynthesis from lanosterol. Molecular cloning, tissue distribution, expression, chromosomal localization, and regulation of rat 7-dehydrocholesterol reductase, a Smith-Lemli-Opitz syndrome-related protein. J Biol Chem 274:14624-14631.
5. Batta AK, Salen G, Tint GS, Shefer S. 1995. Identification of 19-nor- 5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome. J Lipid Res 36:2413-2418.
6. Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL. 2002. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 10:237-245.
7. Brown MS, Goldstein JL. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 96:11041-11048.
8. Chen G, Li HM, Chen YR, Gu XS, Duan S. 2007. Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C. Glia 55:1509-1518.
9. Dietschy JM, Turley SD. 2001. Cholesterol metabolism in the brain. Curr Opin Lipidol 12:105-112.
10. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. 2004. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86:839-848.
11. Fernandez-Alvarez A, Tur G, Lopez-Rodas G, Casado M. 2008. Reciprocal regulation of the human sterol regulatory element binding protein (SREBP)-1a promoter by Sp1 and EGR-1 transcription factors. FEBS Lett 582:177-184.
12. Fitzky BU, Moebius FF, Asaoka H, Waage-Baudet H, Xu L, Xu G, Maeda N, Kluckman K, Hiller S, Yu H, Batta AK, Shefer S, Chen T, Salen G, Sulik K, Simoni RD, Ness GC, Glossmann H, Patel SB, Tint GS. 2001. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/ RSH syndrome. J Clin Invest 108:905-915.
13. Freeman MR, Cinar B, Kim J, Mukhopadhyay NK, Di Vizio D, Adam RM, Solomon KR. 2007. Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes. Steroids 72:210-217.
14. Goldstein JL, DeBose-Boyd RA, Brown MS. 2006. Protein sensors for membrane sterols. Cell 124:35-46.
15. Hashimoto K, Prada S, Lopez AP, Hoyos JG, Escobar M. 1998. CHILD syndrome with linear eruptions, hypopigmented bands, and verruciform xanthoma. Pediatr Dermatol 15:360-366.
16. Honda A, Batta AK, Salen G, Tint GS, Chen TS, Shefer S. 1997. Screening for abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome: rapid determination of plasma 7-dehydrocholesterol by ultraviolet spectrometry. Am J Med Genet 68:288-293.
17. Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131.
18. Iba K, Albrechtsen R, Gilpin B, Frohlich C, Loechel F, Zolkiewska A, Ishiguro K, Kojima T, Liu W, Langford JK, Sanderson RD, Brakebusch C, Fassler R, Wewer UM. 2000. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol 149:1143-1156.
19. Jira PE, Waterham HR, Wanders RJ, Smeitink JA, Sengers RC, Wevers RA. 2003. Smith-Lemli-Opitz syndrome and the DHCR7 gene. Ann Hum Genet 67:269-280.
20. Jurevics H, Morell P. 1995. Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem 64:895-901.
21. Jurevics HA, Kidwai FZ, Morell P. 1997. Sources of cholesterol during development of the rat fetus and fetal organs. J Lipid Res 38:723-733.
22. Keller RK, Arnold TP, Fliesler SJ. 2004. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J Lipid Res 45:347-355.
23. Korade Z, Kenworthy A. 2008. Lipid rafts, cholesterol, and the brain. Neuropharmacology (in press).
24. Korade Z, Mi Z, Portugal C, Schor NF. 2007. Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain. Neurobiol Aging 28:1522-1531.
25. Korn BS, Shimomura I, Bashmakov Y, Hammer RE, Horton JD, Goldstein JL, Brown MS. 1998. Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N). J Clin Invest 102:2050-2060.
26. Kurrasch DM, Huang J, Wilkie TM, Repa JJ. 2004. Quantitative realtime polymerase chain reaction measurement of regulators of G-protein signaling mRNA levels in mouse tissues. Methods Enzymol 389:3-15.
27. Kuwabara PE, Labouesse M. 2002. The sterol-sensing domain: multiple families, a unique role? Trends Genet 18:193-201.
28. Luskey KL, Stevens B. 1985. Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation. J Biol Chem 260:10271-10277.
29. Lutton C. 1991. Dietary cholesterol, membrane cholesterol and cholesterol synthesis. Biochimie 73:1327-1334.
30. Marcos J, Guo LW, Wilson WK, Porter FD, Shackleton C. 2004. The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli- Opitz syndrome) to neurosteroid production. Steroids 69:51-60.
31. Maxfield FR, Tabas I. 2005. Role of cholesterol and lipid organization in disease. Nature 438:612-621.
32. McMullen MR, Pritchard MT, Wang Q, Millward CA, Croniger CM, Nagy LE. 2005. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 128:2066-2076.
33. Milbrandt J. 1987. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238:797-799.
34. Mirnics K, Pevsner J. 2004. Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 7:434-439.
35. Mirnics K, Levitt P, Lewis DA. 2006. Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 60:163-176.
36. Mochizuki S, Okada Y. 2007. ADAMs in cancer cell proliferation and progression. Cancer Sci 98:621-628.
37. Nes WR. 1985. A comparison of methods for the identification of sterols. Methods Enzymol 111:3-37.
38. Paul CA, Boegle AK, Maue RA. 2004. Before the loss: neuronal dysfunction in Niemann-Pick Type C disease. Biochim Biophys Acta 1685:63-76.
39. Pfrieger FW. 2003. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays 25:72-78.
40. Pike LJ. 2003. Lipid rafts: bringing order to chaos. J Lipid Res 44:655-667.
41. Pike LJ. 2005. Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim Biophys Acta 1746:260-273.
42. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. 2006. GenePattern 2.0. Nat Genet 38:500-501.
43. Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D. 2008. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 90:369-379.
44. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA. 2005. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8:468-475.
45. Sikora DM, Ruggiero M, Petit-Kekel K, Merkens LS, Connor WE, Steiner RD. 2004. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome. J Pediatr 144:783-791.
46. Silverman ES, Collins T. 1999. Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol 154:665-670.
47. Singh P, Paila YD, Chattopadhyay A. 2007. Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin(1A) receptor: implications in SLOS. Biochem Biophys Res Commun 358:495-499.
48. Smith DW, Lemli L, Opitz JM. 1964. A newly recognized syndrome of multiple congenital anomalies. J Pediatr 64:210-217.
49. Song BL, Javitt NB, DeBose-Boyd RA. 2005. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab 1:179-189.
50. Stoffel-Wagner B. 2001. Neurosteroid metabolism in the human brain. Eur J Endocrinol 145:669-679.
51. Strandberg TE, Tilvis RS. 1988. Physiological and pharmacological regulation of small intestinal cholesterol synthesis. Gen Pharmacol 19:321-329.
52. Suzuki S, Numakawa T, Shimazu K, Koshimizu H, Hara T, Hatanaka H, Mei L, Lu B, Kojima M. 2004. BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. J Cell Biol 167:1205-1215.
53. Suzuki S, Kiyosue K, Hazama S, Ogura A, Kashihara M, Hara T, Koshimizu H, Kojima M. 2007. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J Neurosci 27:6417-6427.
54. Tellier E, Canault M, Rebsomen L, Bonardo B, Juhan-Vague I, Nalbone G, Peiretti F. 2006. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res 312:3969-3980.
55. Tellier E, Canault M, Poggi M, Bonardo B, Nicolay A, Alessi MC, Nalbone G, Peiretti F. 2008. HDLs activate ADAM17-dependent shedding. J Cell Physiol 214:687-693.
56. Tierney E, Nwokoro NA, Kelley RI. 2000. Behavioral phenotype of RSH/ Smith-Lemli-Opitz syndrome. Ment Retard Dev Disabil Res Rev 6:131-134.
57. Tint GS, Seller M, Hughes-Benzie R, Batta AK, Shefer S, Genest D, Irons M, Elias E, Salen G. 1995. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. J Lipid Res 36:89-95.
58. Tsutsui K. 2008. Progesterone biosynthesis and action in the developing neuron. Endocrinology (in press).
59. Tsutsui K, Sakamoto H, Shikimi H, Ukena K. 2004. Organizing actions of neurosteroids in the Purkinje neuron. Neurosci Res 49:273-279.
60. Waage-Baudet H, Dunty WC Jr, Dehart DB, Hiller S, Sulik KK. 2005. Immunohistochemical and microarray analyses of a mouse model for the Smith-Lemli-Opitz syndrome. Dev Neurosci 27:378-396.
61. Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson JA. 2002. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc Natl Acad Sci U S A 99:13878-13883.
62. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77:53-62.
63. Wassif CA, Vied D, Tsokos M, Connor WE, Steiner RD, Porter FD. 2002. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts. Mol Genet Metab 75:325-334.
64. Weber LW, Boll M, Stampfl A. 2004. Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol 10:3081-3087.
65. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75:187-197.